Tumor-Related Gene Changes in Immunosuppressive Syrian Hamster Cholangiocarcinoma

The results of a previous study demonstrated that prednisolone enhanced cholangiocarcinogenesis. Therefore, to clarify molecular changes during immunosuppressive cholangiocarcinogenesis, Syrian hamsters were divided into 8 groups: uninfected controls; immunosuppressed Syrian hamsters using prednisol...

Full description

Saved in:
Bibliographic Details
Published inPathology oncology research Vol. 19; no. 4; pp. 785 - 794
Main Authors Juasook, Amornrat, Aukkanimart, Ratchadawan, Boonmars, Thidarut, Sudsarn, Pakkayanee, Wonkchalee, Nadchanan, Laummaunwai, Porntip, Sriraj, Pranee
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.10.2013
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The results of a previous study demonstrated that prednisolone enhanced cholangiocarcinogenesis. Therefore, to clarify molecular changes during immunosuppressive cholangiocarcinogenesis, Syrian hamsters were divided into 8 groups: uninfected controls; immunosuppressed Syrian hamsters using prednisolone (P); normal Syrian hamsters administered N -nitrosodimethylamine (ND); immunosuppressed Syrian hamsters administered N -nitrosodimethylamine (ND is ); normal Syrian hamsters infected with Opisthorchis viverrini (OV); immunosuppressed Syrian hamsters infected with O. viverrini (OV is ); normal Syrian hamsters infected with O. viverrini and administered N -nitrosodimethylamine (CCA); and immunosuppressed Syrian hamsters infected with O. viverrini and administered N -nitrosodimethylamine (CCA is ). Syrian hamster livers were used for analysis of tumor-related gene expression and immunohistochemistry through cytokeratin 19 (CK19) and proliferating cell nuclear antigen (PCNA) staining. The tumor-related gene expression results show that CCA is groups at all time points exhibited upregulation of COX-2, IL-6, SOD1, CAT and iNOS and downregulation of p53, which correlated with the predominant expression of CK19 and PCNA in liver tissue. These results suggest that prednisolone enhances cholangiocarcinoma development, which was confirmed by molecular changes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1219-4956
1532-2807
DOI:10.1007/s12253-013-9645-x